Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Total monthly reach
Estimated from 3 chart positions in 3 markets.
By chart position
- 🇲🇽MX · Medicine#13100K to 300K
- 🇯🇵JP · Medicine#20100K to 300K
- 🇹🇭TH · Medicine#156500 to 3K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
100K to 302K🎙 Weekly cadence·20 episodes·Last published 3w ago - Monthly Reach
Unique listeners across all episodes (30 days)
201K to 603K🇲🇽50%🇯🇵50%+1 more - Active Followers
Loyal subscribers who consistently listen
80K to 241K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
Recent episodes
Sara Tartof and Matan Yechezkel on durability of doxycycline effectiveness against syphilis, gonorrhoea, and chlamydia after implementation of post-exposure prophylaxis in southern California
May 7, 2026
25m 48s
Jenny Clarke and Herve Semukunzi
Mar 9, 2026
20m 59s
Julia Moore Vogel and Danilo Buonsenso on long COVID
Dec 19, 2025
27m 33s
In Conversation with Steven Tong and Joshua Davis on adaptive platform trials
Oct 23, 2025
25m 48s
Anna Odone, Jesus Rodriguez-Manzano, and Alex Howard on artificial intelligence and infectious diseases
Sep 16, 2025
29m 12s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Description | Length | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 5/7/26 |  Sara Tartof and Matan Yechezkel on durability of doxycycline effectiveness against syphilis, gonorrhoea, and chlamydia after implementation of post-exposure prophylaxis in southern California | Sara Tartof and Matan Yechezkel discuss a new article in The Lancet Infectious Diseases about emerging doxycycline resistance against gonorrhoea and its wider implications for the implementation of doxycycline and the prevention of bacterial sexually transmitted infections. Click here to read the full article: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(26)00123-4/fulltext The Lancet Infectious Diseases in conversation with... is part of the Lancet Group podcast offering. Editorial team: editor-in-chief Ursula Hofer, deputy editor Marco De Ambrogi, and senior editors Syeda Saleha Hassan and Phoebe Hall Podcast editing: Matteo Simonetti Visit https://www.thelancet.com/multimedia to learn more about our multimedia offering. Find the best science for better lives at lancet.comFollow us today at...https://thelancet.bsky.social/https://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv | 25m 48s | ||||||
| 3/9/26 | Jenny Clarke and Herve Semukunzi | Dr Jenny Clarke and Herve Semukunzi discuss a study they and colleagues recently published with us titled ‘Infection- and vaccine-induced mpox antibodies: validation of a combined mpox IgG ELISA during the clade 1b outbreak in Rwanda’. They also discuss the reasons for the paucity of validated serological assays for mpox, particularly in outbreak regions where they are most urgently needed. Click here to read the full article: https://www.thelancet.com/journals/laninf/... | 20m 59s | ||||||
| 12/19/25 | Julia Moore Vogel and Danilo Buonsenso on long COVID | Dr Julia Moore Vogel and Dr Danilo Buonsenso discuss various aspects of long COVID including epidemiology, pathophysiology, underlying mechanisms, management, latest research developments, difficulties in conducting clinical trials, and future research priorities. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com... | 27m 33s | ||||||
| 10/23/25 | In Conversation with Steven Tong and Joshua Davis on adaptive platform trials | Professors Steven Tong and Joshua Davis discuss all aspects of adaptive platform trials including advantages, disadvantages, differences from conventional trials, and tips for setting up and assessing them. They also highlight several adaptive platform trials currently in the pipeline that could influence infectious disease clinical practise in the future. Click here to read our latest issue Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://ins... | 25m 48s | ||||||
| 9/16/25 | Anna Odone, Jesus Rodriguez-Manzano, and Alex Howard on artificial intelligence and infectious diseases | Professor Ana Odone, Dr Jesus Rodriguez-Manzano, and Dr Alex Howard discuss their new Series of papers on artificial intelligence and infectious diseases intended to support the infectious diseases community in understanding this evolving landscape and in actively shaping artificial intelligence integration into practice. Read the full Series here: https://www.thelancet.com/series-do/artificial-intelligence-and-infectious-diseases?dgcid=buzzsprout_icw_podcast_laninfaiandid25_laninf Continue t... | 29m 12s | ||||||
| 8/11/25 | Catherine Liu and Joshua Hill on prevention and management of infections in people who are immunocompromised | Drs Catherine Liu and Joshua Hill of the Fred Hutchinson Cancer Center discuss their new Series of papers on the prevention and management of infections in people who are immunocompromised, with a focus on prevention of infections and diagnostic and antimicrobial stewardship. Read the Series papers: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(25)00345-7/fulltext?dgcid=buzzsprout_icw_podcast_August_25_laninf https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(25... | 18m 27s | ||||||
| 7/9/25 | Lilian Tina Minja and Norbert Heinrich on TB drug development | Lilian Tina Minja and Norbert Heinrich discuss the SUDUCO and DECODE trials in The Lancet Infectious Diseases on two new promising TB drugs, sutezolid and delpazolid, respectively. They also discuss the wider implications of the findings of these trials for TB drug development and treatment. Read the trials: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(25)00213-0/fulltext?dgcid=buzzsprout_icw_podcast_July_25_laninf https://www.thelancet.com/journals/laninf/article/PIIS1473-... | 29m 53s | ||||||
| 6/10/25 | Leonardo Basso and Juan Pablo Torres on the NIRSE-CL study of nirsevimab in Chile | Leonardo Basso and Juan Pablo Torres discuss their study in The Lancet Infectious Diseases on the effectiveness and impact of the first season of Chile's national immunisation programme with nirsevimab. They discuss the evidence that led to the design and implementation of the programme, its impact on RSV burden and the Chilean health system, and lessons for other countries in the region and beyond. Read the full article at: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(25)0... | 15m 27s | ||||||
| 4/14/25 | Jan Felix Drexler and Fernando Bozza on Oropouche virus | Jan Felix Drexler and Fernando Bozza discuss their recent study published in the journal— “The spatio-temporal ecology of Oropouche virus: a laboratory-based modelling study across Latin America” and its wider implications for Oropouche virus and other arboviruses transmission, expansion, surveillance, and control. Read the full article: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(25)00110-0/fulltext?dgcid=buzzsprout_icw_podcast_14-04-25_laninf Continue this conversation o... | 35m 17s | ||||||
| 2/23/24 | Prasad Kulkarni on dengue monoclonal antibodies | Prasad Kulkarni discusses a new Phase I trial in The Lancet Infectious Diseases on a dengue monoclonal antibody also known as VIS513 in healthy adults. In addition, he highlights the wider implications of this for dengue control and drug development. Read the full article: https://www.thelancet.com/journals/laninf/article/ S1473-3099(24)00030-6/fulltext?dgcid=buzzsprout_icw_podcast_generic_laninf Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https... | 18m 53s | ||||||
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 1/8/24 | Oriol Mitjà on treatment of early syphilis in adults | Oriol Mitjà discusses a new trial in The Lancet Infectious Diseases on the use of oral linezolid compared with benzathine penicillin G for the treatment of early syphilis in adults. He also highlights what the trial means for treatment of syphilis. Read the full article: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(23)00683-7/fulltext?dgcid=buzzsprout_icw_podcast_generic_laninf Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https... | 15m 25s | ||||||
| 11/10/23 | Sofia Viegas and Stefan Niemann on emerging bedaquiline resistance in Mozambique | Sofia Viegas and Stefan Niemann discuss a new article in The Lancet Infectious Diseases about emerging bedaquiline resistance in Mozambique and its implications for drug resistant tuberculosis and the fight to end tuberculosis. Read the full article: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(23)00498-X/fulltext?dgcid=buzzsprout_icw_podcast_generic_laninf Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thel... | 24m 35s | ||||||
| 9/27/22 | Luciano Moreira and Henrik Salje on Wolbachia control of mosquito-borne infections | Luciano Moreira and Henrik Salje discuss a new article in The Lancet Infectious Diseases describing the use of the Wolbachia bacteria to control the spread of mosquito-borne dengue and chikungunya in Rio de Janeiro, Brazil. Read the full article: Estimating the effect of the wMel release programme on the incidence of dengue and chikungunya in Rio de Janeiro, Brazil Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup ... | 17m 01s | ||||||
| 9/27/22 | Richard Maude on malaria chemoprophylaxis in Cambodia | Richard Maude discusses a new article in The Lancet Infectious Diseases that assesses the efficacy of malaria chemoprophylaxis among forest goers in Cambodia. Read the full article: Antimalarial chemoprophylaxis for forest goers in southeast Asia Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv | 12m 44s | ||||||
| 7/15/22 | Ben Cowling on COVID-19 vaccines in Hong Kong | Ben Cowling discusses a new article in The Lancet Infectious Diseases describing the protection that vaccines are providing against COVID-19 in Hong Kong. Read the full article: Vaccine effectiveness of one, two, and three doses of BNT162b2 and CoronaVac against COVID-19 in Hong Kong Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lance... | 20m 58s | ||||||
| 5/26/22 | Hugh Adler on monkeypox in the UK | Hugh Adler discusses a new article in The Lancet Infectious Diseases describing the management and the clinical features for seven patients with monkeypox hospitalised in the UK between 2018 and 2021. Read the full article: Clinical features and management of human monkeypox: a retrospective observational study in the UK Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal ... | 18m 17s | ||||||
| 12/14/21 | Beate Kampmann, Karen Keddy, and Peter Ghazal on applying big data to childhood infectious diseases in LMICs | Prof Beate Kampmann, Dr Karen Keddy, and Prof Peter Ghazal discuss a new cross-journal Series in The Lancet Infectious Diseases and EBioMedicine addressing the potential for and challenge of applying big data to childhood infectious diseases in LMICs. Read the full Series: https://www.thelancet.com/series/big-data-childhood-infections-LMICs Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.co... | 22m 16s | ||||||
| 10/12/21 | Laura Cooper and Sam Okiror on polio eradication in Africa | A new article highlights how changing immunity profiles motivate the need for better responses to outbreaks of polio in Africa. Read the full article: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00453-9/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv | 21m 34s | ||||||
| 8/19/21 | Paul Chapman on a hookworm vaccine | Paul Chapman and colleagues presents the results of an innovative trial assessing the safety of vaccinating healthy volunteers with attenuated Necator americanus hookworm larvae. Read the full article: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00153-5/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/... | 20m 57s | ||||||
| 5/27/21 | Josep Llibre on preventing SARS-CoV-2 transmission at concerts | Josep Llibre discusses a trial on the impact of same-day testing for SARS-CoV-2 infection before a concert on new COVID-19 cases in Barcelona, Spain. Read the full article: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00268-1/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelan... | 8m 10s | ||||||
| 3/25/21 | Yap Boum on COVID-19 testing in low resource settings | Yap Boum (MSF) discusses his study done in Cameroon, which developed a promising testing strategy for COVID-19 to optimise the available resources. Read the full article: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00132-8/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelance... | 11m 21s | ||||||
Showing 21 of 21
Sponsor Intelligence
Sign in to see which brands sponsor this podcast, their ad offers, and promo codes.
Chart Positions
5 placements across 3 markets.
Chart Positions
5 placements across 3 markets.